UTAH MEDICAL PRODUCTS INC - Common Stock (UTMD)

CUSIP: 917488108

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Equity / Common Stock
Shares outstanding
3,203,885
Total 13F shares
2,695,866
Share change
+28,092
Total reported value
$257,857,946
Price per share
$95.70
Number of holders
96
Value change
+$3,901,787
Number of buys
51
Number of sells
33

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 917488108?
CUSIP 917488108 identifies UTMD - UTAH MEDICAL PRODUCTS INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of UTMD - UTAH MEDICAL PRODUCTS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
15%
488,255
$43,089,000 31 Mar 2019
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
9.9%
316,154
$27,901,000 31 Mar 2019
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
7.4%
238,248
$21,025,000 31 Mar 2019
13F
VANGUARD GROUP INC
13F
Company
5.8%
186,776
$16,483,000 31 Mar 2019
13F
BlackRock Finance, Inc.
13F
Company
5.5%
177,595
$15,673,000 31 Mar 2019
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
5.5%
176,568
$15,582,000 31 Mar 2019
13F
LAZARD ASSET MANAGEMENT LLC
13F
Company
4.8%
155,262
$13,701,000 31 Mar 2019
13F
STATE STREET CORP
13F
Company
2.3%
72,679
$6,435,000 31 Mar 2019
13F
LOOMIS SAYLES & CO L P
13F
Company
2%
63,854
$5,635,000 31 Mar 2019
13F
Ancora Advisors LLC
13F
Company
1.3%
41,141
$5,542,000 31 Mar 2019
13F
THB ASSET MANAGEMENT
13F
Company
1.8%
57,924
$5,111,000 31 Mar 2019
13F
Ranger Investment Management, L.P.
13F
Company
1.7%
55,536
$4,901,000 31 Mar 2019
13F
NORTHERN TRUST CORP
13F
Company
1.7%
55,099
$4,863,000 31 Mar 2019
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.6%
52,250
$4,610,000 31 Mar 2019
13F
Russell Investments Group, Ltd.
13F
Company
1.5%
48,905
$4,316,000 31 Mar 2019
13F
RICE HALL JAMES & ASSOCIATES, LLC
13F
Company
1.4%
44,989
$3,970,000 31 Mar 2019
13F
ROYCE & ASSOCIATES LP
13F
Company
1%
33,245
$2,934,000 31 Mar 2019
13F
Clean Yield Group
13F
Company
0.88%
28,085
$2,479,000 31 Mar 2019
13F
Bank of New York Mellon Corp
13F
Company
0.73%
23,306
$2,057,000 31 Mar 2019
13F
JPMORGAN CHASE & CO
13F
Company
0.7%
22,400
$1,976,000 31 Mar 2019
13F
MARTINGALE ASSET MANAGEMENT L P
13F
Company
0.69%
22,102
$1,951,000 31 Mar 2019
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.61%
19,454
$1,717,000 31 Mar 2019
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.59%
18,993
$1,676,000 31 Mar 2019
13F
WEDGE CAPITAL MANAGEMENT L L P/NC
13F
Company
0.58%
18,527
$1,635,000 31 Mar 2019
13F
RAYMOND JAMES & ASSOCIATES
13F
Company
0.53%
16,979
$1,498,000 31 Mar 2019
13F
Port Capital LLC
13F
Company
0.53%
16,964
$1,497,000 31 Mar 2019
13F
NATIXIS ADVISORS, LLC
13F
Company
0.51%
16,484
$1,455,000 31 Mar 2019
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.5%
16,112
$1,422,000 31 Mar 2019
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.43%
13,900
$1,227,000 31 Mar 2019
13F
BESSEMER GROUP INC
13F
Company
0.37%
11,800
$1,041,000 31 Mar 2019
13F
MORGAN DEMPSEY CAPITAL MANAGEMENT LLC
13F
Company
0.36%
11,416
$1,007,000 31 Mar 2019
13F
Cardinal Capital Management
13F
Company
0.32%
10,163
$896,000 31 Mar 2019
13F
US BANCORP \DE\
13F
Company
0.31%
10,079
$889,000 31 Mar 2019
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.26%
8,425
$744,000 31 Mar 2019
13F
OXFORD ASSET MANAGEMENT LLP
13F
Company
0.23%
7,212
$636,000 31 Mar 2019
13F
UBS Group AG
13F
Company
0.22%
7,200
$635,000 31 Mar 2019
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.22%
6,936
$612,000 31 Mar 2019
13F
PRUDENTIAL FINANCIAL INC
13F
Company
0.22%
6,900
$609,000 31 Mar 2019
13F
STRS OHIO
13F
Company
0.21%
6,800
$600,000 31 Mar 2019
13F
ISTHMUS PARTNERS, LLC
13F
Company
0.29%
9,187
$581,000 31 Mar 2019
13F
CHICAGO EQUITY PARTNERS LLC
13F
Company
0.19%
6,145
$542,000 31 Mar 2019
13F
MARSHALL WACE, LLP
13F
Company
0.19%
6,050
$534,000 31 Mar 2019
13F
Allianz Asset Management GmbH
13F
Company
0.18%
5,684
$502,000 31 Mar 2019
13F
TEACHERS ADVISORS, LLC
13F
Company
0.18%
5,664
$500,000 31 Mar 2019
13F
DEUTSCHE BANK AG\
13F
Company
0.17%
5,594
$491,000 31 Mar 2019
13F
Advisory Services Network, LLC
13F
Company
0.17%
5,380
$475,000 31 Mar 2019
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.17%
5,380
$475,000 31 Mar 2019
13F
Teton Advisors, Inc.
13F
Company
0.15%
4,800
$424,000 31 Mar 2019
13F
RHUMBLINE ADVISERS
13F
Company
0.15%
4,672
$412,000 31 Mar 2019
13F
Janney Montgomery Scott LLC
13F
Company
0.15%
4,663
$412,000 31 Mar 2019
13F

Institutional Holders of UTAH MEDICAL PRODUCTS INC - Common Stock (UTMD) as of Q2 2019

As of 30 Jun 2019, UTAH MEDICAL PRODUCTS INC - Common Stock (UTMD) was held by 96 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,695,866 shares. The largest 10 holders included FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, Russell Investments Group, Ltd., RICE HALL JAMES & ASSOCIATES, LLC, STATE STREET CORP, and LOOMIS SAYLES & CO L P. This page lists 96 institutional shareholders reporting positions in this security for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2019 vs Q1 2019 Across Filers

Q1 2019 holders
90
Q2 2019 holders
96
Holder diff
6
Investor Q1 2019 Shares Q2 2019 Shares Share Diff Share Chg % Q1 2019 Value $ Q2 2019 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.